In addition, to further explore whether RAD52 is associated with neurodegenerative disease, we analyzed the normalized expression of RAD52 mRNA between the AD group and the control group using the data from Gene Expression Omnibus (GEO) (accessed on 5 November 2024) related to neurodegenerative diseases. This evidence concerns the gene RAD52 and Alzheimer disease.